Close

CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products

Go back to CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products
(NASDAQ: CLGN) Delayed: 5.41 +0.01 (0.19%)
Previous Close $5.40    52 Week High
Open $5.42    52 Week Low
Day High $5.42    P/E N/A 
Day Low $5.41    EPS
Volume 1,040